Movatterモバイル変換


[0]ホーム

URL:


CN116099080A - Monitoring method, central station and central monitoring system - Google Patents

Monitoring method, central station and central monitoring system
Download PDF

Info

Publication number
CN116099080A
CN116099080ACN202111328097.5ACN202111328097ACN116099080ACN 116099080 ACN116099080 ACN 116099080ACN 202111328097 ACN202111328097 ACN 202111328097ACN 116099080 ACN116099080 ACN 116099080A
Authority
CN
China
Prior art keywords
data
infusion
target
parameter
physiological parameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111328097.5A
Other languages
Chinese (zh)
Inventor
韦梦莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edan Instruments Inc
Original Assignee
Edan Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edan Instruments IncfiledCriticalEdan Instruments Inc
Priority to CN202111328097.5ApriorityCriticalpatent/CN116099080A/en
Publication of CN116099080ApublicationCriticalpatent/CN116099080A/en
Pendinglegal-statusCriticalCurrent

Links

Images

Classifications

Landscapes

Abstract

The invention relates to the technical field of medical equipment, in particular to a monitoring method, a central station and a central monitoring system, wherein the monitoring method comprises the steps of acquiring physiological parameter data and infusion data of at least one target object at the same time; the physiological parameter data and the transfusion data are displayed in corresponding parameter display areas in a monitoring main interface so as to carry out joint analysis on vital sign changes of the target objects, wherein the monitoring main interface comprises a plurality of parameter display areas, and each parameter display area corresponds to each target object; and after receiving the operation object for joint analysis, adjusting and setting the infusion data, and displaying the adjusted and set infusion data in a parameter display area. The monitoring method performs joint observation on the physiological parameter data and the infusion data, is convenient for medical staff to know the vital sign condition and the infusion system condition of a target object, and improves the monitoring efficiency.

Description

Translated fromChinese
监护方法、中央站及中央监护系统Monitoring method, central station and central monitoring system

技术领域technical field

本发明涉及医疗设备技术领域,具体涉及监护方法、中央站及中央监护系统。The invention relates to the technical field of medical equipment, in particular to a monitoring method, a central station and a central monitoring system.

背景技术Background technique

目前,输注系统作为一种能够对输注信息进行集中显示和管理的装置,对于临床应用具有重要意义。一般的输注系统仅关注于当前正在使用的输注设备的信息,例如显示实时的输液进度、提供报警信息的显示,作为一种对床旁输注设备的远程监控装置,这样的方法的确可以极大的提升医疗护理效率,同时,输注系统能够方便护士会更快速地定位到需要进行护理的患者。At present, the infusion system, as a device capable of centrally displaying and managing infusion information, is of great significance for clinical applications. The general infusion system only focuses on the information of the infusion equipment currently in use, such as displaying real-time infusion progress and providing alarm information display. As a remote monitoring device for bedside infusion equipment, such a method can indeed It greatly improves the efficiency of medical care, and at the same time, the infusion system can facilitate nurses to locate patients who need care more quickly.

然而,在监护过程中,医护人员不仅要掌握输液设备的信息,还需要获知生理参数监护设备的信息,以对目标对象进行及时的监护。然而,现行的输注系统对于医护人员而言,需要学习的操作的系统种类过于繁多,在实际使用过程中并没有合理高效的提升医护人员的工作效率,导致监护效率较低。However, during the monitoring process, medical personnel not only need to know the information of the infusion equipment, but also need to know the information of the physiological parameter monitoring equipment, so as to monitor the target object in time. However, for the current infusion system, there are too many types of systems that need to be learned by the medical staff. In the actual use process, the work efficiency of the medical staff has not been improved reasonably and efficiently, resulting in low monitoring efficiency.

发明内容Contents of the invention

有鉴于此,本发明实施例提供了一种监护方法、中央站及中央监护系统,以解决现有监护方法所带来的监护效率低的问题。In view of this, an embodiment of the present invention provides a monitoring method, a central station, and a central monitoring system to solve the problem of low monitoring efficiency caused by existing monitoring methods.

根据第一方面,本发明实施例提供了一种监护方法,包括:According to the first aspect, an embodiment of the present invention provides a monitoring method, including:

获取至少一个目标对象在同一时间的生理参数数据以及输液数据;Acquiring physiological parameter data and infusion data of at least one target subject at the same time;

将所述生理参数数据以及输液数据显示在监护主界面中对应的参数显示区,以对所述目标对象的生命体征变化进行联合分析,所述监护主界面包括多个所述参数显示区,每一所述参数显示区与每一所述目标对象对应;The physiological parameter data and the infusion data are displayed in the corresponding parameter display area in the monitoring main interface to jointly analyze the changes in the vital signs of the target object. The monitoring main interface includes a plurality of the parameter display areas, each a parameter display area corresponding to each target object;

接收操作对象进行联合分析后,对所述输液数据的调整设置,并在所述参数显示区显示调整设置后的所述输液数据。After the joint analysis is performed on the received operation object, the infusion data is adjusted and set, and the adjusted and set infusion data is displayed in the parameter display area.

本发明实施例提供的监护方法,在同一监护主界面上同时显示生理参数数据以及输液数据,即,对生理参数数据以及输液数据进行联合观察,以对目标对象的生命体征变化进行联合分析,进而在联合分析后对输液数据进行调整设置后,在参数显示区显示调整设置后的输液数据,方便医护人员了解目标对象的生命体征状况和输注系统状况,使得医护人员可以获得相应的信息,提高了监护效率。In the monitoring method provided by the embodiment of the present invention, the physiological parameter data and the infusion data are simultaneously displayed on the same monitoring main interface, that is, the physiological parameter data and the infusion data are jointly observed to jointly analyze the changes in the vital signs of the target object, and then After the infusion data is adjusted and set after the joint analysis, the adjusted infusion data will be displayed in the parameter display area, which is convenient for medical staff to understand the status of the target's vital signs and the status of the infusion system, so that the medical staff can obtain corresponding information and improve monitoring efficiency.

结合第一方面,在第一方面第一实施方式中,所述监护主界面还包括波形显示区,每一所述波形显示区与每一所述参数显示区对应,所述方法还包括:With reference to the first aspect, in the first implementation manner of the first aspect, the monitoring main interface further includes a waveform display area, each of the waveform display areas corresponds to each of the parameter display areas, and the method further includes:

在所述波形显示区显示所述生理参数数据的波形。The waveform of the physiological parameter data is displayed in the waveform display area.

本发明实施例提供的监护方法,在监护主界面同时显示生理参数数据的波形以及对应的数据值,便于医护人员不仅能够获知生理参数的变化情况,还可以及时知晓各个生理参数的实时值。The monitoring method provided by the embodiment of the present invention simultaneously displays the waveform of the physiological parameter data and the corresponding data value on the monitoring main interface, so that the medical staff can not only know the change of the physiological parameter, but also know the real-time value of each physiological parameter in time.

结合第一方面,或第一方面第一实施方式,在第一方面第二实施方式中,所述输液数据包括输液剩余时间以及输液报警标识,所述参数显示区包括剩余时间显示区以及报警显示区,所述将所述生理参数数据以及输液数据显示在监护主界面中对应参数显示区,包括:With reference to the first aspect, or the first embodiment of the first aspect, in the second embodiment of the first aspect, the infusion data includes the remaining time of infusion and an infusion alarm mark, and the parameter display area includes a remaining time display area and an alarm display area, the physiological parameter data and infusion data are displayed in the corresponding parameter display area in the monitoring main interface, including:

将所述输液剩余时间显示在对应参数显示区的所述剩余时间显示区,并将所述输液报警标识显示在对应参数显示区的所述报警显示区,所述输液报警标识与所述输液剩余时间对应。Displaying the remaining time of the infusion in the remaining time display area of the corresponding parameter display area, and displaying the infusion alarm mark in the alarm display area of the corresponding parameter display area, the infusion alarm mark and the remaining time of the infusion Time corresponds.

本发明实施例提供的监护方法,将输液剩余时间以及输液报警标识同时显示,可以方便医护人员基于输液报警标识调整设置需要采取的行动和工作流程。The monitoring method provided by the embodiment of the present invention can simultaneously display the remaining time of infusion and the infusion alarm mark, which can facilitate the medical staff to adjust and set the actions and work flow that need to be taken based on the infusion alarm mark.

结合第一方面,在第一方面第三实施方式中,所述参数显示区包括输液显示区,所述方法还包括:With reference to the first aspect, in the third implementation manner of the first aspect, the parameter display area includes an infusion display area, and the method further includes:

响应于对所述输液显示区的选择操作,显示药物统计分析界面,所述药物统计分析界面包括药物显示区以及生理参数显示区;In response to the selection operation of the infusion display area, a drug statistical analysis interface is displayed, and the drug statistical analysis interface includes a drug display area and a physiological parameter display area;

响应于对所述生理参数数据以及所述输液数据的选择操作,确定目标药物的输液数据以及目标生理参数数据;In response to the selection operation on the physiological parameter data and the infusion data, determine the infusion data of the target drug and the target physiological parameter data;

将所述目标药物的输液数据显示在所述药物显示区,并将所述目标生理参数数据显示在所述生理参数显示区。The infusion data of the target drug is displayed in the drug display area, and the target physiological parameter data is displayed in the physiological parameter display area.

本发明实施例提供的监护方法,在药物统计分析界面对药物的输液数据以及目标生理参数数据进行统计分析,便于医护人员了解输注药物对目标对象生命体征的影响,后续可以通过输注药物变化引起的生命体征变化去调整药物的剂量、速度,用于辅助临床进行精准护理。The monitoring method provided by the embodiment of the present invention performs statistical analysis on the drug infusion data and target physiological parameter data on the drug statistical analysis interface, which is convenient for medical staff to understand the impact of the infused drug on the vital signs of the target object, and the follow-up can be changed through the infusion of the drug. The changes in vital signs caused by the patient can adjust the dose and speed of the drug, which is used to assist clinical precision care.

结合第一方面第三实施方式,在第一方面第四实施方式中,所述药物统计分析界面还包括目标选择区,所述响应于对所述生理参数数据以及所述输液数据的选择操作,确定目标药物的输液数据以及目标生理参数数据,包括:With reference to the third embodiment of the first aspect, in the fourth embodiment of the first aspect, the drug statistical analysis interface further includes a target selection area, and in response to the selection operation of the physiological parameter data and the infusion data, Determine the infusion data of the target drug and the target physiological parameter data, including:

响应于对所述目标选择区中参数选择标签的选择操作,显示参数选择界面;displaying a parameter selection interface in response to a selection operation on a parameter selection label in the target selection area;

响应于对所述参数选择界面中生理参数的选择操作,确定所述目标生理参数;determining the target physiological parameter in response to a selection operation of the physiological parameter in the parameter selection interface;

基于所述生理参数数据以及所述目标生理参数,确定所述目标生理参数数据。Based on the physiological parameter data and the target physiological parameter, the target physiological parameter data is determined.

本发明实施例提供的监护方法,提供参数选择标签便于医护人员对于不同的目标对象设置不同的生理参数进行显示,从而可以针对目标对象进行个性化监护。The monitoring method provided by the embodiment of the present invention provides a parameter selection label to facilitate medical staff to set different physiological parameters for different target objects for display, so that personalized monitoring can be performed for the target object.

结合第一方面第四实施方式,在第一方面第五实施方式中,所述参数选择界面包括参数列表以及参数组列表,所述参数组列表中每个条目包括至少两个生理参数,所述响应于对所述参数选择界面中生理参数的选择操作,确定所述目标生理参数,包括:With reference to the fourth embodiment of the first aspect, in the fifth embodiment of the first aspect, the parameter selection interface includes a parameter list and a parameter group list, each entry in the parameter group list includes at least two physiological parameters, and the In response to the selection operation of the physiological parameter in the parameter selection interface, determining the target physiological parameter includes:

响应于对所述参数列表或所述参数组列表的选择操作,确定所述目标生理参数。The target physiological parameter is determined in response to a selection operation of the parameter list or the parameter set list.

本发明实施例提供的监护方法,提供参数组列表,通过通参数组列表中条目的选择,就可以一次确定至少两个生理参数,减少了对参数列表的选择次数,提高了监护效率。The monitoring method provided by the embodiment of the present invention provides a list of parameter groups. By selecting items in the list of parameter groups, at least two physiological parameters can be determined at one time, which reduces the number of selections of the parameter list and improves monitoring efficiency.

结合第一方面第四实施方式,在第一方面第六实施方式中,所述响应于对所述参数选择界面中生理参数的选择操作,确定所述目标生理参数,还包括:With reference to the fourth embodiment of the first aspect, in the sixth embodiment of the first aspect, the determining the target physiological parameter in response to the selection operation of the physiological parameter in the parameter selection interface further includes:

响应于对所述目标生理参数的创建参数组的操作,创建目标参数组。A target parameter set is created in response to the create parameter set operation on the target physiological parameter.

本发明实施例提供的监护方法,提供目标参数组的自适应创建,可以依据医护人员的需求进行生理参数的组合,便于后续参数的选择。The monitoring method provided by the embodiment of the present invention provides self-adaptive creation of target parameter groups, and can combine physiological parameters according to the needs of medical staff, so as to facilitate the selection of subsequent parameters.

结合第一方面第四实施方式,在第一方面第七实施方式中,所述响应于对所述生理参数数据以及所述输液数据的选择操作,确定目标药物的输液数据以及目标生理参数数据,包括:With reference to the fourth embodiment of the first aspect, in the seventh embodiment of the first aspect, in response to the selection operation of the physiological parameter data and the infusion data, determining the infusion data of the target drug and the target physiological parameter data, include:

响应于对所述目标选择区中药物选择标签的选择操作,显示药物选择界面;displaying a drug selection interface in response to a selection operation on the drug selection label in the target selection area;

响应于对所述药物选择界面中药物的选择操作,确定所述目标药物;determining the target drug in response to a drug selection operation in the drug selection interface;

基于所述输液数据以及所述目标药物,确定所述目标药物的输液数据。Based on the infusion data and the target drug, determine the infusion data of the target drug.

本发明实施例提供的监护方法,通过针对目标对象进行目标药物的个性化选择,对于不同的目标对象配置不同的目标药物,便于医护人员进行监护。In the monitoring method provided by the embodiment of the present invention, through the personalized selection of the target drug for the target object, different target drugs are configured for different target objects, which is convenient for medical staff to monitor.

结合第一方面第七实施方式,在第一方面第八实施方式中,所述基于所述输液数据以及所述目标药物,确定所述目标药物的输液数据,包括:With reference to the seventh implementation of the first aspect, in the eighth implementation of the first aspect, the determination of the infusion data of the target drug based on the infusion data and the target drug includes:

响应于对所述目标选择区中药物曲线标签的选择操作,显示药物曲线选择界面;Displaying a drug curve selection interface in response to the selection operation of the drug curve label in the target selection area;

响应于对所述药物曲线选择界面中药物属性的选择操作,确定所述目标药物的药物属性,所述药物属性包括输注速度以及输注累积量;In response to the selection operation of the drug attribute in the drug curve selection interface, determine the drug attribute of the target drug, the drug attribute includes an infusion rate and a cumulative infusion amount;

基于所述输液数据、所述目标药物以及所述目标药物的药物属性,确定所述目标药物的输液数据。Based on the infusion data, the target drug, and the drug attribute of the target drug, determine the infusion data of the target drug.

根据第二方面,本发明实施例还提供了一种中央站,包括:According to the second aspect, the embodiment of the present invention also provides a central station, including:

显示界面,存储器和处理器,所述显示界面、所述存储器和所述处理器之间互相通信连接,所述存储器中存储有计算机指令,所述处理器通过执行所述计算机指令,从而执行本发明第一方面或第一方面任一项实施方式中所述的监护方法。A display interface, a memory and a processor, the display interface, the memory and the processor are connected in communication with each other, the memory stores computer instructions, and the processor executes the computer instructions by executing the computer instructions. The monitoring method described in the first aspect of the invention or any one of the implementations of the first aspect.

本发明实施例提供的中央站,在同一监护主界面上同时显示生理参数数据以及输液数据,即,对生理参数数据以及输液数据进行联合观察,以对目标对象的生命体征变化进行联合分析,进而在联合分析后对输液数据进行调整设置后,在参数显示区显示调整设置后的输液数据,方便医护人员了解目标对象的生命体征状况和输注系统状况,使得医护人员可以获得相应的信息,提高了监护效率。The central station provided by the embodiment of the present invention simultaneously displays the physiological parameter data and the infusion data on the same monitoring main interface, that is, jointly observes the physiological parameter data and the infusion data to jointly analyze the changes in the vital signs of the target object, and then After the infusion data is adjusted and set after the joint analysis, the adjusted infusion data will be displayed in the parameter display area, which is convenient for medical staff to understand the status of the target's vital signs and the status of the infusion system, so that the medical staff can obtain corresponding information and improve monitoring efficiency.

根据第三方面,本发明实施例还提供了一种中央监护系统,包括:According to a third aspect, an embodiment of the present invention also provides a central monitoring system, including:

输注系统,用于获取目标对象的输液数据;The infusion system is used to obtain the infusion data of the target object;

生理参数监护设备,用于获取所述目标对象的生理参数数据;Physiological parameter monitoring equipment, used to obtain the physiological parameter data of the target object;

本发明第二方面所述的中央站,与所述输注系统以及所述生理参数监护设备通信连接。The central station according to the second aspect of the present invention is communicatively connected with the infusion system and the physiological parameter monitoring equipment.

本发明实施例提供的中央监护系统,在中央站的同一监护主界面上同时显示来自生理参数监护设备的生理参数数据以及输注系统的输液数据,即,对生理参数数据以及输液数据进行联合观察,以对目标对象的生命体征变化进行联合分析,方便医护人员了解目标对象的生命体征状况和输注系统状况,使得医护人员可以获得相应的信息,提高了监护效率。The central monitoring system provided by the embodiment of the present invention simultaneously displays the physiological parameter data from the physiological parameter monitoring device and the infusion data of the infusion system on the same monitoring main interface of the central station, that is, jointly observes the physiological parameter data and the infusion data , to conduct joint analysis on the changes in the vital signs of the target object, so that the medical staff can understand the status of the vital signs of the target object and the status of the infusion system, so that the medical staff can obtain corresponding information and improve the efficiency of monitoring.

附图说明Description of drawings

为了更清楚地说明本发明具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the specific implementation of the present invention or the technical solutions in the prior art, the following will briefly introduce the accompanying drawings that need to be used in the specific implementation or description of the prior art. Obviously, the accompanying drawings in the following description The drawings show some implementations of the present invention, and those skilled in the art can obtain other drawings based on these drawings without any creative effort.

图1是根据本发明实施例提供的中央站的硬件结构示意图;Fig. 1 is a schematic diagram of the hardware structure of a central station provided according to an embodiment of the present invention;

图2是根据本发明实施例提供的中央监护系统的结构框图;Fig. 2 is a structural block diagram of the central monitoring system provided according to an embodiment of the present invention;

图3是根据本发明实施例的监护方法的流程图;Fig. 3 is the flowchart of monitoring method according to the embodiment of the present invention;

图4是根据本发明实施例的监护主界面的示意图;Fig. 4 is a schematic diagram of the monitoring main interface according to an embodiment of the present invention;

图5是根据本发明实施例的监护方法的流程图;Fig. 5 is the flowchart of monitoring method according to the embodiment of the present invention;

图6是根据本发明实施例的监护主界面的示意图;Fig. 6 is a schematic diagram of the monitoring main interface according to an embodiment of the present invention;

图7是根据本发明实施例的监护方法的流程图;Fig. 7 is a flowchart of a monitoring method according to an embodiment of the present invention;

图8是根据本发明实施例的药物统计分析界面的示意图;Fig. 8 is a schematic diagram of a drug statistical analysis interface according to an embodiment of the present invention;

图9是根据本发明实施例的参数选择界面的示意图;9 is a schematic diagram of a parameter selection interface according to an embodiment of the present invention;

图10是根据本发明实施例的药物选择界面的示意图;Fig. 10 is a schematic diagram of a drug selection interface according to an embodiment of the present invention;

图11是根据本发明实施例的药物曲线选择界面。Fig. 11 is a drug curve selection interface according to an embodiment of the present invention.

具体实施方式Detailed ways

为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without making creative efforts belong to the protection scope of the present invention.

本发明实施例提供的监护方法,将目标对象的输液数据与生理参数数据进行联合监护,以对目标对象的生命体征变化进行联合分析,实现了生命体征与输注信息的实时显示。同时,在联合分析后操作对象对输液数据进行调整设置,并将调整设置后的输液数据实时显示在监护主界面,能够方便医护人员同步监测目标对象的生理参数和输注进度,并实时知晓调整后的输液数据,避免了多个不同系统的同时操作带来的工作复杂。In the monitoring method provided by the embodiment of the present invention, the infusion data and physiological parameter data of the target object are jointly monitored to jointly analyze the changes of the vital signs of the target object, and the real-time display of vital signs and infusion information is realized. At the same time, after the joint analysis, the operation object adjusts the infusion data and displays the adjusted infusion data on the main monitoring interface in real time, which can facilitate the medical staff to simultaneously monitor the physiological parameters and infusion progress of the target object, and know the adjustment in real time The final infusion data avoids the complicated work caused by the simultaneous operation of multiple different systems.

进一步地,在监护方法中还提供了生理参数与药物联动的分析界面,能够为临床辅助诊断提供有效的凭据和临床决策支持,极大推进了精准医疗的发展,降低了目标对象的治疗风险。Furthermore, the monitoring method also provides an analysis interface for the linkage between physiological parameters and drugs, which can provide effective evidence and clinical decision support for clinical auxiliary diagnosis, greatly promote the development of precision medicine, and reduce the treatment risk of target objects.

进一步地,监护方法还支持进行可视化等个性化配置的使用,能够为不同科室提供不同的信息选择方案,降低科室负荷、提高监护效率。Furthermore, the monitoring method also supports the use of personalized configurations such as visualization, which can provide different information selection schemes for different departments, reduce the load on departments, and improve monitoring efficiency.

本发明实施例提供一种中央站,与输注系统以及生理参数监护设备连接,输注系统用于确定目标对象的输液数据,生理参数监护设备用于确定目标对象的生理参数数据。中央站分别从输注系统以及生理参数监护设备中获取到输液数据以及生理参数数据,并将者两种数据显示在同一监护主界面的参数显示区。同时,在中央站的显示主界面提供至少一个参数显示区,用于同时对至少一个目标对象进行监护,每个目标对象均具有对应的参数显示区,不同的参数显示区中具有目标对象的身份标识以进行区分。An embodiment of the present invention provides a central station connected to an infusion system and a physiological parameter monitoring device. The infusion system is used to determine the infusion data of the target object, and the physiological parameter monitoring device is used to determine the physiological parameter data of the target object. The central station obtains infusion data and physiological parameter data from the infusion system and physiological parameter monitoring equipment respectively, and displays the two data in the parameter display area of the same monitoring main interface. At the same time, at least one parameter display area is provided on the display main interface of the central station, which is used to monitor at least one target object at the same time, each target object has a corresponding parameter display area, and different parameter display areas have the identity of the target object identified to distinguish.

该中央站可以设置在护士站,用于远程对各个目标对象进行监护。其中,在中央站的监护主界面上可以同时显示多个目标对象的输液数据以及生理参数数据。例如,在中央站同时对10位目标对象进行监护,在监护主界面上最多只能同时显示4位目标对象的实时数据,因此,需要对10位目标对象的实时数据进行分页显示。当然,监护主界面上最多能同时显示的目标对象的数量可以根据实际需求进行调整设置,在此对其并不做任何限定。The central station can be set at a nurse's station for remote monitoring of each target object. Among them, the infusion data and physiological parameter data of multiple target objects can be displayed simultaneously on the monitoring main interface of the central station. For example, if 10 target objects are monitored at the same time at the central station, the real-time data of 4 target objects can only be displayed at most on the monitoring main interface at the same time. Therefore, it is necessary to display the real-time data of 10 target objects in pages. Of course, the maximum number of target objects that can be displayed simultaneously on the monitoring main interface can be adjusted and set according to actual needs, and there is no limitation here.

中央站还具有人机交互功能,医护人员通过操作该中央站,针对各个目标对象的监护数据进行个性化设置,从而实现对各个目标对象进行个性化监护。例如,输注系统所提供的输液数据有多种,医护人员可以根据需求针对各个目标对象进行输液数据的监控;同样地,生理参数监护设备所提供的生理参数也有多种,医护人员可以根据需求对各个目标对象的生理参数进行监护,从多个生理参数中确定出目标生理参数。The central station also has the function of human-computer interaction. By operating the central station, medical staff can personalize the monitoring data of each target object, so as to realize personalized monitoring of each target object. For example, there are many kinds of infusion data provided by the infusion system, and the medical staff can monitor the infusion data for each target object according to the needs; similarly, there are also various physiological parameters provided by the physiological parameter monitoring equipment, and the medical staff can monitor the infusion data according to the needs. The physiological parameters of each target object are monitored, and the target physiological parameters are determined from multiple physiological parameters.

关于中央站的具体监护方法将在下文中进行详细描述。The specific monitoring method of the central station will be described in detail below.

图1是本发明可选实施例提供的一种中央站的结构示意图,如图1所示,该中央站可以包括:至少一个处理器101,例如CPU(Central Processing Unit,中央处理器),至少一个通信接口103,存储器104,至少一个通信总线102,以及显示界面(图1中未示出)。其中,通信总线102用于实现这些组件之间的连接通信。其中,通信接口103可以包括显示屏(Display)、键盘(Keyboard),可选通信接口103还可以包括标准的有线接口、无线接口。存储器104可以是高速RAM存储器(Random Access Memory,易挥发性随机存取存储器),也可以是非不稳定的存储器(non-volatile memory),例如至少一个磁盘存储器。存储器104可选的还可以是至少一个位于远离前述处理器101的存储装置。其中存储器104中存储应用程序,且处理器101调用存储器104中存储的程序代码,以用于执行下述任一所述的监护方法的步骤。Fig. 1 is the structural representation of a kind of central station that optional embodiment of the present invention provides, as shown in Fig. 1, this central station can comprise: at least oneprocessor 101, such as CPU (Central Processing Unit, central processing unit), at least Acommunication interface 103,memory 104, at least onecommunication bus 102, and a display interface (not shown in FIG. 1). Wherein, thecommunication bus 102 is used to realize connection and communication between these components. Wherein, thecommunication interface 103 may include a display screen (Display) and a keyboard (Keyboard), and theoptional communication interface 103 may also include a standard wired interface and a wireless interface. Thememory 104 may be a high-speed RAM memory (Random Access Memory, volatile random access memory), or a non-volatile memory (non-volatile memory), such as at least one disk memory. Optionally, thememory 104 may also be at least one storage device located away from theaforementioned processor 101 . Wherein thememory 104 stores an application program, and theprocessor 101 invokes the program code stored in thememory 104 to execute the steps of any monitoring method described below.

其中,通信总线102可以是外设部件互连标准(peripheral componentinterconnect,简称PCI)总线或扩展工业标准结构(extended industry standardarchitecture,简称EISA)总线等。通信总线102可以分为地址总线、数据总线、控制总线等。为便于表示,图1中仅用一条粗线表示,但并不表示仅有一根总线或一种类型的总线。Wherein, thecommunication bus 102 may be a peripheral component interconnect (PCI for short) bus or an extended industry standard architecture (EISA for short) bus or the like. Thecommunication bus 102 can be divided into an address bus, a data bus, a control bus, and the like. For ease of representation, only one thick line is used in FIG. 1 , but it does not mean that there is only one bus or one type of bus.

其中,存储器104可以包括易失性存储器(英文:volatile memory),例如随机存取存储器(英文:random-access memory,缩写:RAM);存储器也可以包括非易失性存储器(英文:non-volatile memory),例如快闪存储器(英文:flash memory),硬盘(英文:hard diskdrive,缩写:HDD)或固态硬盘(英文:solid-state drive,缩写:SSD);存储器104还可以包括上述种类的存储器的组合。Wherein, thememory 104 may include a volatile memory (English: volatile memory), such as a random-access memory (English: random-access memory, abbreviated: RAM); the memory may also include a non-volatile memory (English: non-volatile memory), such as flash memory (English: flash memory), hard disk (English: hard diskdrive, abbreviated: HDD) or solid-state hard drive (English: solid-state drive, abbreviated: SSD);memory 104 can also include the memory of above-mentioned kind The combination.

其中,处理器101可以是中央处理器(英文:central processing unit,缩写:CPU),网络处理器(英文:network processor,缩写:NP)或者CPU和NP的组合。Wherein, theprocessor 101 may be a central processing unit (English: central processing unit, abbreviated: CPU), a network processor (English: network processor, abbreviated: NP) or a combination of CPU and NP.

其中,处理器101还可以进一步包括硬件芯片。上述硬件芯片可以是专用集成电路(英文:application-specific integrated circuit,缩写:ASIC),可编程逻辑器件(英文:programmable logic device,缩写:PLD)或其组合。上述PLD可以是复杂可编程逻辑器件(英文:complex programmable logic device,缩写:CPLD),现场可编程逻辑门阵列(英文:field-programmable gate array,缩写:FPGA),通用阵列逻辑(英文:generic arraylogic,缩写:GAL)或其任意组合。Wherein, theprocessor 101 may further include a hardware chip. The aforementioned hardware chip may be an application-specific integrated circuit (English: application-specific integrated circuit, abbreviation: ASIC), a programmable logic device (English: programmable logic device, abbreviation: PLD) or a combination thereof. The above PLD can be a complex programmable logic device (English: complex programmable logic device, abbreviated: CPLD), field programmable logic gate array (English: field-programmable gate array, abbreviated: FPGA), general array logic (English: generic arraylogic , Abbreviation: GAL) or any combination thereof.

可选地,存储器104还用于存储程序指令。处理器101可以调用程序指令,实现如本申请任一实施例中所示的监护方法。Optionally, thememory 104 is also used to store program instructions. Theprocessor 101 can invoke program instructions to implement the monitoring method shown in any embodiment of the present application.

本实施例提供的中央站,在同一监护主界面上同时显示生理参数数据以及输液数据,即,对生理参数数据以及输液数据进行联合观察,以对目标对象的生命体征变化进行联合分析,进而根据联合分析的结果对输液数据进行输注速度调整等设置,并在参数显示区显示调整设置后的输液数据,方便医护人员实时监护目标对象的生命体征状况和输注系统状况,提高了监护效率。The central station provided in this embodiment simultaneously displays the physiological parameter data and the infusion data on the same monitoring main interface, that is, jointly observes the physiological parameter data and the infusion data, so as to jointly analyze the changes in the vital signs of the target object, and then according to Based on the results of the joint analysis, the infusion speed adjustment and other settings are performed on the infusion data, and the adjusted infusion data are displayed in the parameter display area, which is convenient for medical staff to monitor the vital signs and infusion system status of the target object in real time, and improves the monitoring efficiency.

本发明实施例还提供一种中央监护系统,如图2所示,该中央监护系统包括中央站10、输注系统20以及生理参数监护设备30。关于中央站10的具体描述请参见上文所述,在此不再赘述。The embodiment of the present invention also provides a central monitoring system. As shown in FIG. 2 , the central monitoring system includes acentral station 10 , aninfusion system 20 and a physiologicalparameter monitoring device 30 . For the specific description of thecentral station 10, please refer to the above, and details are not repeated here.

具体地,输注系统20用于获取目标对象的输液数据;生理参数监护设备30用于获取目标对象的生理参数数据;中央站10与输注系统20以及生理参数监护设备30通信连接,用于获取各个目标对象的输液数据以及生理参数数据。Specifically, theinfusion system 20 is used to obtain the infusion data of the target object; the physiologicalparameter monitoring device 30 is used to obtain the physiological parameter data of the target object; thecentral station 10 is connected in communication with theinfusion system 20 and the physiologicalparameter monitoring device 30 for The infusion data and physiological parameter data of each target object are obtained.

其中,中央监护系统中所包括的中央站10、输注系统20以及生理参数监护设备30的具体数量可以根据实际需求进行设置。且中央站10所连接的输注系统20以及生理参数监护设备30的数量也是根据实际需求进行设置的,在此对其并不做任何限定。生理参数监护设备30的具体类型可以根据目标对象进行设置,例如,可以采用同一生理参数监护设备30同时监测目标对象的各个生理参数,也可以采用多个生理参数监护设备30对同一目标对象的各个生理参数进行监测,等等。Wherein, the specific numbers of thecentral station 10, theinfusion system 20, and the physiologicalparameter monitoring equipment 30 included in the central monitoring system can be set according to actual needs. Moreover, the number ofinfusion systems 20 and physiologicalparameter monitoring devices 30 connected to thecentral station 10 is also set according to actual needs, and is not limited here. The specific type of the physiologicalparameter monitoring device 30 can be set according to the target object. For example, the same physiologicalparameter monitoring device 30 can be used to simultaneously monitor the various physiological parameters of the target object, or multiple physiologicalparameter monitoring devices 30 can be used to monitor each physiological parameter of the same target object. Physiological parameters are monitored, among others.

本实施例提供的中央监护系统,在中央站的同一监护主界面上同时显示来自生理参数监护设备的生理参数数据以及输注系统的输液数据,即,对生理参数数据以及输液数据进行联合观察,以对目标对象的生命体征变化进行联合分析,进而根据联合分析的结果对输液数据进行输注速度调整等设置,并在参数显示区显示调整设置后的输液数据,方便医护人员实时监护目标对象的生命体征状况和输注系统状况,提高了监护效率。The central monitoring system provided in this embodiment simultaneously displays the physiological parameter data from the physiological parameter monitoring device and the infusion data of the infusion system on the same monitoring main interface of the central station, that is, jointly observes the physiological parameter data and the infusion data, Through the combined analysis of the changes in the vital signs of the target object, and then according to the results of the joint analysis, the infusion data can be adjusted and other settings are made, and the adjusted infusion data can be displayed in the parameter display area, which is convenient for medical staff to monitor the target object’s status in real time. Vital sign status and infusion system status improve monitoring efficiency.

根据本发明实施例,提供了一种监护方法实施例,需要说明的是,在附图的流程图示出的步骤可以在诸如一组计算机可执行指令的计算机系统中执行,并且,虽然在流程图中示出了逻辑顺序,但是在某些情况下,可以以不同于此处的顺序执行所示出或描述的步骤。According to an embodiment of the present invention, an embodiment of a monitoring method is provided. It should be noted that the steps shown in the flow chart of the accompanying drawings can be executed in a computer system such as a set of computer-executable instructions, and, although in the flow chart The figures show a logical order, but in some cases the steps shown or described may be performed in an order different from that shown or described herein.

在本实施例中提供了一种监护方法,可用于上述的中央站中,图3是根据本发明实施例的监护方法的流程图,如图3所示,该流程包括如下步骤:A monitoring method is provided in this embodiment, which can be used in the above-mentioned central station. FIG. 3 is a flow chart of the monitoring method according to an embodiment of the present invention. As shown in FIG. 3 , the process includes the following steps:

S11,获取至少一个目标对象在同一时间的生理参数数据以及输液数据。S11. Acquire physiological parameter data and infusion data of at least one target object at the same time.

如上文所述,中央站与输注系统以及生理参数监护设备通信连接。中央站在同一时间分别从输注系统获取目标对象的输液数据,从生理参数监护设备获取目标对象的生理参数数据。As noted above, the central station is communicatively linked to the infusion system and physiological parameter monitoring equipment. The central station obtains the infusion data of the target object from the infusion system and the physiological parameter data of the target object from the physiological parameter monitoring device at the same time.

具体地,中央站可以基于HL7通信协议收集并解析来自输注系统以及生理参数监护设备的数据,为二者建立关联关系提供基础。在输注过程中,医护人员会根据医嘱为目标对象输注某种治疗药物并设置好输注速度,同时监测该目标对象的生理参数的数据,确保输注过程中的目标对象的生命体征正常。Specifically, the central station can collect and analyze data from the infusion system and physiological parameter monitoring equipment based on the HL7 communication protocol, providing a basis for establishing an association relationship between the two. During the infusion process, the medical staff will infuse a certain therapeutic drug and set the infusion speed for the target subject according to the doctor's order, and at the same time monitor the data of the target subject's physiological parameters to ensure that the target subject's vital signs are normal during the infusion process .

生理参数数据包括但不限于血压、血氧、心率、脉率等等,当然也可以根据不同的科室设置不同的生理参数,具体可以根据应用场景进行设置。Physiological parameter data includes but not limited to blood pressure, blood oxygen, heart rate, pulse rate, etc. Of course, different physiological parameters can also be set according to different departments, specifically according to the application scenario.

以上获取输液数据和生理参数数据的方式是本发明方案的实施基础,该种通讯方式仅仅是其中的一种通讯形式,本发明的保护范围并不限于此。The above method of acquiring infusion data and physiological parameter data is the implementation basis of the solution of the present invention, and this communication method is only one of the communication forms, and the protection scope of the present invention is not limited thereto.

S12,将生理参数数据以及输液数据显示在监护主界面中对应的参数显示区,以对所述目标对象的生命体征变化进行联合分析。S12, displaying the physiological parameter data and the infusion data in the corresponding parameter display area of the monitoring main interface, so as to jointly analyze the changes of the vital signs of the target object.

其中,所述监护主界面包括多个参数显示区,每一所述参数显示区与每一所述目标对象对应。Wherein, the monitoring main interface includes a plurality of parameter display areas, and each parameter display area corresponds to each target object.

如图4所示,监护主界面包括多个参数显示区,中央站将获取到的生理参数数据以及输液数据显示在对应的参数显示区。需要说明的是,图4是一种示例,并不限定本发明的保护范围。As shown in Figure 4, the monitoring main interface includes multiple parameter display areas, and the central station displays the acquired physiological parameter data and infusion data in the corresponding parameter display areas. It should be noted that FIG. 4 is an example and does not limit the protection scope of the present invention.

例如,监护主界面最多可以同时显示5位目标对象的实时数据,相应地,监护主界面就可以划分为5个参数显示区,在每个参数显示区与目标对象一一对应。中央站在获取来自同一目标对象的生理参数数据以及波形数据之后,将其显示在对应的参数显示区。For example, the monitoring main interface can display the real-time data of up to 5 target objects at the same time. Correspondingly, the monitoring main interface can be divided into 5 parameter display areas, and each parameter display area corresponds to the target object one by one. After acquiring the physiological parameter data and waveform data from the same target object, the central station displays them in the corresponding parameter display area.

可选地,对于各个参数显示区而言,可以包括生理参数显示区以及输液显示区。相应地,各个参数显示区的生理参数显示区用于显示对应的目标对象的生理参数数据,输液显示区用于显示对应的目标对象的输液数据。在划分出的5个参数显示区标注有对应的目标对象的基本信息,例如,姓名、床位等等。Optionally, each parameter display area may include a physiological parameter display area and an infusion display area. Correspondingly, the physiological parameter display area of each parameter display area is used to display the corresponding physiological parameter data of the target subject, and the infusion display area is used to display the corresponding infusion data of the target subject. The 5 divided parameter display areas are marked with the basic information of the corresponding target object, such as name, bed position and so on.

S13,接收操作对象进行联合分析后,对输液数据的调整设置,并在参数显示区显示调整设置后的输液数据。S13, after receiving the operation object for joint analysis, adjusting and setting the infusion data, and displaying the adjusted and set infusion data in the parameter display area.

中央站在对目标对象的生理参数数据以及输液数据进行联合分析后,在监护主界面上显示有联合分析结果。操作对象基于该联合分析结果依据需求对该目标对象的输液数据进行调整设置,该调整设置包括但不限于医护人员结合生理参数数据,对原始的输注数据进行修改,例如,调整原始输注剂的用量;又例如,调整输注速度更大或者更小,或者,在生理参数异常时,关闭输液等。After the central station conducts joint analysis on the physiological parameter data and infusion data of the target object, the joint analysis results are displayed on the main monitoring interface. The operation object adjusts the infusion data of the target object based on the joint analysis results according to the needs, and the adjustment settings include but not limited to the medical staff to modify the original infusion data in combination with the physiological parameter data, for example, to adjust the original infusion agent For another example, adjust the infusion rate to be larger or smaller, or shut down the infusion when the physiological parameters are abnormal.

本实施例提供的监护方法,在同一监护主界面上同时显示生理参数数据以及输液数据,即,对生理参数数据以及输液数据进行联合观察,以对所述目标对象的生命体征变化进行联合分析,进而在联合分析后对输液数据进行调整设置后,在参数显示区显示调整设置后的输液数据,方便医护人员了解目标对象的生命体征状况和输注系统状况,使得医护人员可以获得相应的信息,提高了监护效率。In the monitoring method provided in this embodiment, the physiological parameter data and the infusion data are simultaneously displayed on the same monitoring main interface, that is, the physiological parameter data and the infusion data are jointly observed to jointly analyze the changes in the vital signs of the target object, Then, after the infusion data is adjusted and set after the joint analysis, the adjusted infusion data will be displayed in the parameter display area, which is convenient for the medical staff to understand the target object's vital signs and infusion system status, so that the medical staff can obtain the corresponding information, Improved monitoring efficiency.

在本实施例中提供了一种监护方法,可用于上述的中央站中,图5是根据本发明实施例的监护方法的流程图,如图5所示,该流程包括如下步骤:A monitoring method is provided in this embodiment, which can be used in the above-mentioned central station. FIG. 5 is a flow chart of the monitoring method according to an embodiment of the present invention. As shown in FIG. 5, the process includes the following steps:

S21,获取至少一个目标对象在同一时间的生理参数数据以及输液数据。S21. Acquire physiological parameter data and infusion data of at least one target object at the same time.

详细请参见图3所示实施例的S11,在此不再赘述。For details, refer to S11 in the embodiment shown in FIG. 3 , and details are not repeated here.

S22,将生理参数数据以及输液数据显示在监护主界面中对应的参数显示区,以对目标对象的生命体征变化进行联合分析。S22, displaying the physiological parameter data and the infusion data in the corresponding parameter display area of the monitoring main interface, so as to jointly analyze the changes of the vital signs of the target object.

对于生理参数而言,其实时数据的显示方式可以是波形,也可以是数据值。基于此,监护主界面还包括波形显示区。对于输液数据而言,其包括输液剩余时间以及输液报警标识。其中,输液报警标识可以采用不同的颜色进行区分,不同的颜色标识不同的优先级。例如,如表1所示:For physiological parameters, the real-time data can be displayed in the form of waveforms or data values. Based on this, the monitoring main interface also includes a waveform display area. For the infusion data, it includes the remaining infusion time and the infusion alarm flag. Wherein, the infusion alarm signs can be distinguished by different colors, and different colors indicate different priorities. For example, as shown in Table 1:

表1输液报警标识Table 1 Infusion alarm identification

Figure BDA0003347895510000111
Figure BDA0003347895510000111

当然,输液报警标识也并不限于上文所述的颜色区分,也可以其他方式区分。Of course, the infusion alarm signs are not limited to the above-mentioned color distinctions, and can also be distinguished in other ways.

进一步地,所述参数显示区包括剩余时间显示区以及报警显示区。基于此,上述S22包括:Further, the parameter display area includes a remaining time display area and an alarm display area. Based on this, the above S22 includes:

S221,在波形显示区显示生理参数数据的波形。S221. Display the waveform of the physiological parameter data in the waveform display area.

中央站将生理参数数据中的部分或全部采用波形的方式表示,将生理参数数据中的部分或全部采用数据值的方式表示,具体将哪些生理参数数据采用波形表示,哪些生理参数采用数据值表示,具体根据实际应用进行设置。其中,中央站将用于波形显示的生理参数数据显示在对应波形显示区,将用于数据值显示的生理参数数据显示在对应参数显示区。The central station represents part or all of the physiological parameter data in the form of waveforms, and part or all of the physiological parameter data in the form of data values. Specifically, which physiological parameter data are represented by waveforms and which physiological parameters are represented by data values , and set it according to the actual application. Wherein, the central station displays the physiological parameter data for waveform display in the corresponding waveform display area, and displays the physiological parameter data for data value display in the corresponding parameter display area.

可选地,也可以将同一生理参数,既采用波形方式表示,又采用数据值方式表示。Optionally, the same physiological parameter may also be expressed in both a waveform and a data value.

S222,将输液剩余时间显示在对应参数显示区的剩余时间显示区,并将输液报警标识显示在对应参数显示区的报警显示区。S222. Display the remaining time of infusion in the remaining time display area corresponding to the parameter display area, and display the infusion alarm mark in the alarm display area corresponding to the parameter display area.

其中,输液报警标识与输液剩余时间对应。Wherein, the infusion alarm sign corresponds to the remaining time of infusion.

如上文所述,输液剩余时间以及输液报警标识是从输注系统中获取到的。监护设备将输液剩余时间显示在对应参数显示区的剩余时间显示区,将输液报警标识显示在对应参数显示区的报警显示区。As mentioned above, the remaining infusion time and the infusion warning sign are obtained from the infusion system. The monitoring device displays the remaining time of infusion in the remaining time display area of the corresponding parameter display area, and displays the infusion alarm mark in the alarm display area of the corresponding parameter display area.

例如,图6示出了监护主界面201的一种可选实施方式。医护人员在该界面可以观察多位不同目标对象的实时监护数据。中央站将获取到的输液数据以及生理参数数据显示到该监护主界面上。其中,202为波形显示区,显示对应生理参数的实时波形,例如心电波形、呼吸波形和血氧波形等;203为目标对象的信息,包括目标对象的床号以及姓名等,便于医护人员识别出需要到床旁进行处理的目标对象是哪一位,节省医护人员的找寻时间;206为参数显示区中的数据显示区,用于显示目标对象的生理参数的数据值,医护人员可以快速定位目标对象出现异常的生理参数。204为报警显示区,用于表示目标对象的输液报警标识,根据实际状态不同以不同颜色标记该图标,不同的颜色用于指示医护人员可能需要对不同的目标对象采取行动;205为剩余时间显示区,用于辅助医护人员判断输注进度。For example, FIG. 6 shows an optional implementation of the monitoringmain interface 201 . Medical personnel can observe the real-time monitoring data of multiple different target objects on this interface. The central station displays the obtained infusion data and physiological parameter data on the monitoring main interface. Among them, 202 is a waveform display area, which displays real-time waveforms corresponding to physiological parameters, such as ECG waveforms, respiratory waveforms, and blood oxygen waveforms; 203 is the information of the target object, including the bed number and name of the target object, which is convenient for medical staff to identify Find out which target object needs to be processed at the bedside, which saves the search time of the medical staff; 206 is the data display area in the parameter display area, which is used to display the data value of the physiological parameters of the target object, and the medical staff can quickly locate Subject exhibits abnormal physiological parameters. 204 is an alarm display area, which is used to represent the infusion alarm mark of the target object, and the icon is marked with different colors according to the actual state, and different colors are used to indicate that the medical staff may need to take action on different target objects; 205 is the remaining time display The zone is used to assist the medical staff to judge the progress of the infusion.

医护人员可以在监护主界面201下实时查看来自输注系统以及生理参数监护设备的实时数据,通过报警标识告知医护人员当前目标对象的生命体征状态和输注系统状况,使得医护人员可以获得相应的信息。基于此,医护人员可以根据目标对象的监护数据调整设置需要采取的行动和工作流程。其中,对于报警标识而言,并不限于输液报警信息,还包括生理参数的报警信息。例如,在中央站中设置有各个生理参数的正常范围,若目标对象的某一生理参数数据不在正常范围内,则在该监护主界面中也同样进行显示。例如,若01床的血压偏高,那么,在显示血压值时可以采用颜色进行区分,以提示医护人员此时需要进行相应的处理,即医护人员可以知悉正在发生的报警信息,并对高优先级的紧急报警采取相应的行动,提升护理质量。The medical staff can view the real-time data from the infusion system and physiological parameter monitoring equipment in real time under themain monitoring interface 201, and inform the medical staff of the current vital sign status of the target object and the status of the infusion system through the alarm sign, so that the medical staff can obtain corresponding information. information. Based on this, medical staff can adjust the actions and workflows that need to be taken according to the monitoring data of the target object. Wherein, for the alarm sign, it is not limited to the infusion alarm information, but also includes the alarm information of the physiological parameters. For example, the normal range of each physiological parameter is set in the central station, and if the data of a certain physiological parameter of the target object is not within the normal range, it will also be displayed in the monitoring main interface. For example, if the blood pressure inbed 01 is too high, then the color can be used to distinguish the blood pressure value to remind the medical staff that they need to deal with it at this time. Level emergency alarm to take corresponding actions to improve the quality of care.

S23,接收操作对象进行联合分析后,对输液数据的调整设置,并在参数显示区显示调整设置后的输液数据。S23. After receiving the operation object for joint analysis, adjust and set the infusion data, and display the adjusted and set infusion data in the parameter display area.

详细请参见图3所示实施例的S13,在此不再赘述。For details, refer to S13 in the embodiment shown in FIG. 3 , and details are not repeated here.

本实施例提供的监护方法,在监护主界面同时显示生理参数数据的波形数据以及数据值,便于医护人员不仅能够获知生理参数数据的变化情况,还可以及时知晓各个生理参数数据的实时值。将输液剩余时间以及输液报警标识同时显示,可以方便医护人员基于输液报警标识调整设置需要采取的行动和工作流程。The monitoring method provided by this embodiment simultaneously displays the waveform data and data values of the physiological parameter data on the monitoring main interface, so that the medical staff can not only know the changes of the physiological parameter data, but also know the real-time value of each physiological parameter data in time. Simultaneously displaying the remaining time of infusion and the infusion alarm mark can facilitate the medical staff to adjust and set the actions and workflows that need to be taken based on the infusion alarm mark.

在本实施例中提供了一种监护方法,可用于上述的中央站中,所述参数显示区包括输液显示区,图7是根据本发明实施例的监护方法的流程图,如图7所示,该流程包括如下步骤:In this embodiment, a monitoring method is provided, which can be used in the above-mentioned central station. The parameter display area includes an infusion display area. FIG. 7 is a flow chart of the monitoring method according to an embodiment of the present invention, as shown in FIG. 7 , the process includes the following steps:

S31,获取至少一个目标对象在同一时间的生理参数数据以及输液数据。S31. Acquire physiological parameter data and infusion data of at least one target object at the same time.

详细请参见图3所示实施例的S11,在此不再赘述。For details, refer to S11 in the embodiment shown in FIG. 3 , and details are not repeated here.

S32,将生理参数数据以及输液数据显示在监护主界面中对应的参数显示区,以对目标对象的生命体征变化进行联合分析。S32, displaying the physiological parameter data and the infusion data in the corresponding parameter display area of the monitoring main interface, so as to jointly analyze the changes of the vital signs of the target subject.

详细请参见图5所示实施例的S22,在此不再赘述。For details, refer to S22 in the embodiment shown in FIG. 5 , and details are not repeated here.

S33,响应于对输液显示区的选择操作,显示药物统计分析界面。S33, in response to the selection operation of the infusion display area, displaying a drug statistical analysis interface.

其中,所述药物统计分析界面包括药物显示区以及生理参数显示区。Wherein, the drug statistical analysis interface includes a drug display area and a physiological parameter display area.

当医护人员需要查看输注药物数据与生理参数数据之间的关联关系时,可以选择输液显示区,相应地,中央站响应于对输液显示区的选择操作,显示药物统计分析界面。该药物统计分析界面用于显示输注药物的统计数据以及生理参数数据。即,通过时间将输注药物与生理参数进行相关联。例如,目标对象是从8:00开始输注药物A,那么,在药物统计分析界面的药物显示区可以显示药物A从8:00开始输注速度或输注累积量,在生理参数显示区显示从8:00开始的生理参数数据。When the medical personnel need to view the relationship between the infusion drug data and the physiological parameter data, they can select the infusion display area, and correspondingly, the central station displays the drug statistical analysis interface in response to the selection operation of the infusion display area. The drug statistical analysis interface is used to display the statistical data of infused drugs and physiological parameter data. That is, the infused drug is correlated with the physiological parameter through time. For example, if the target object is to infuse drug A from 8:00, then the infusion speed or cumulative infusion amount of drug A from 8:00 can be displayed in the drug display area of the drug statistical analysis interface, and the physiological parameter display area can display Physiological parameter data from 8:00.

图8示出了药物统计分析界面301的一种可选实施方式,其包括药物显示区303以及生理参数显示区304。对于药物显示区303以及生理参数显示区304显示的是输注药物和生理参数的分析曲线,该分析曲线的横轴是时间轴,反映查看内容随时间的变化趋势,纵轴为对应时刻的参数值。305为纵轴方向的滚动条,306为横轴方向的滚动条,医护人员可以拖动查看更晚时刻的数据和更多参数的趋势分析图。例如,医护人员可以拖动横轴方向的滚动条306查看较晚或较早时刻的数据,拖动纵轴方向的滚动条305可以查看不同的药物或不同的生理参数的趋势分析图。FIG. 8 shows an optional implementation of the drugstatistical analysis interface 301 , which includes adrug display area 303 and a physiologicalparameter display area 304 . For thedrug display area 303 and the physiologicalparameter display area 304, the analysis curves of the infusion drugs and physiological parameters are displayed. The horizontal axis of the analysis curve is the time axis, reflecting the change trend of the viewing content over time, and the vertical axis is the parameter at the corresponding time. value. 305 is a scroll bar in the direction of the vertical axis, and 306 is a scroll bar in the direction of the horizontal axis. The medical staff can drag to view the data at a later time and the trend analysis graph of more parameters. For example, medical staff can drag thescroll bar 306 on the horizontal axis to view data at a later or earlier time, and drag thescroll bar 305 on the vertical axis to view trend analysis graphs of different drugs or different physiological parameters.

S34,响应于对生理参数数据以及输液数据的选择操作,确定目标药物的输液数据以及目标生理参数数据。S34. In response to the selection operation on the physiological parameter data and the infusion data, determine the infusion data of the target drug and the target physiological parameter data.

所述药物统计分析界面还包括目标选择区。例如,图8所示的目标选择区302,该目标选择区302提供有参数选择标签、药物选择标签以及药物曲线标签。基于此,上述S34包括:The drug statistical analysis interface also includes a target selection area. For example, in thetarget selection area 302 shown in FIG. 8 , thetarget selection area 302 is provided with parameter selection tags, drug selection tags, and drug curve tags. Based on this, the above S34 includes:

S341,响应于对目标选择区中参数选择标签的选择操作,显示参数选择界面。S341. Display a parameter selection interface in response to a selection operation on the parameter selection label in the target selection area.

如上文所述,生理参数监护设备所监测的生理参数有很多种,而不同的目标对象可能需要监测的生理参数也不同,医护人员所关心的生理参数不同。因此,中央站提供有参数选择标签,以供医护人员针对不同的监护需求选择相应的生理参数。As mentioned above, there are many kinds of physiological parameters monitored by the physiological parameter monitoring equipment, and different target objects may need to monitor different physiological parameters, and medical staff are concerned about different physiological parameters. Therefore, the central station provides a parameter selection label for medical personnel to select corresponding physiological parameters according to different monitoring needs.

在需要对生理参数进行选择时,医护人员选择目标选择区中的参数选择标签,相应地,中央站响应于该选择操作,显示参数选择界面。其中,在参数选择界面中提供有多种生理参数供医护人员选择。When it is necessary to select a physiological parameter, the medical staff selects the parameter selection label in the target selection area, and accordingly, the central station displays a parameter selection interface in response to the selection operation. Wherein, a variety of physiological parameters are provided in the parameter selection interface for medical personnel to choose.

S342,响应于对参数选择界面中生理参数的选择操作,确定目标生理参数。S342. Determine the target physiological parameter in response to the selection operation of the physiological parameter in the parameter selection interface.

例如,图9示出了参数选择界面的一种可选实施方式,在该参数选择界面提供有多种生理参数,医护人员可以根据需求选择其中的一种或多种。中央站将医护人员选中的生理参数确定为目标生理参数,该目标生理参数是显示在药物统计分析界面的生理参数显示区。For example, FIG. 9 shows an optional implementation of a parameter selection interface, where various physiological parameters are provided, and medical staff can select one or more of them according to requirements. The central station determines the physiological parameter selected by the medical personnel as the target physiological parameter, and the target physiological parameter is displayed in the physiological parameter display area of the drug statistical analysis interface.

在本实施例的一些可选实施方式中,所述参数选择界面包括参数列表以及参数组列表,所述参数组列表中每个条目包括至少两个生理参数。相应地,上述S342可以包括:响应于对参数列表或参数组列表的选择操作,确定目标生理参数。In some optional implementation manners of this embodiment, the parameter selection interface includes a parameter list and a parameter group list, and each entry in the parameter group list includes at least two physiological parameters. Correspondingly, the above S342 may include: determining the target physiological parameter in response to a selection operation on the parameter list or the parameter group list.

如图9所示,在参数选择界面不仅提供有参数列表供医护人员选择,还提供有参数组列表供医护人员选择。其中,参数列表与参数组列表的不同之处在于,对参数列表进行选择时,需要多次进行选择;而对于参数组列表选择时,一次选择就可以选中至少两个生理参数。As shown in FIG. 9 , the parameter selection interface not only provides a parameter list for the medical personnel to select, but also provides a parameter group list for the medical personnel to select. The difference between the parameter list and the parameter group list is that when selecting the parameter list, multiple selections are required; and when selecting the parameter group list, at least two physiological parameters can be selected in one selection.

如图9所示,在参数选择界面401中包括有参数列表402以及参数组列表403。若同样是需要选择基本六参,即心率、呼吸、血压、血氧、脉率以及体温,若在参数列表402中进行选择,需要多次操作;而若在参数组列表403中进行选择,则仅需要选中基本六参这一参数组即可。As shown in FIG. 9 , theparameter selection interface 401 includes aparameter list 402 and aparameter group list 403 . If you also need to select the basic six parameters, namely heart rate, respiration, blood pressure, blood oxygen, pulse rate and body temperature, if you choose in theparameter list 402, you need multiple operations; and if you choose in theparameter group list 403, then You only need to select the parameter group of the basic six parameters.

提供参数组列表,通过通参数组列表中条目的选择,就可以一次确定至少两个生理参数,减少了对参数列表的选择次数,提高了监护效率。A parameter group list is provided, and at least two physiological parameters can be determined at one time by selecting items in the parameter group list, which reduces the number of selections of the parameter list and improves monitoring efficiency.

作为本实施例的一种可选实施方式,上述S342还可以包括:As an optional implementation manner of this embodiment, the above S342 may also include:

响应于对目标生理参数的创建参数组的操作,创建目标参数组。A target parameter set is created in response to the create parameter set operation on the target physiological parameter.

例如,医护人员针对某一护理需求需要同时监测多个参数,则就可以在参数列表中选择这多个参数,再创建目标参数组,就可以将这多个参数作为一个整理。后续在进行选择时,仅需要选中该目标参数组就可以同时选中对应的多个参数了。For example, if medical personnel need to monitor multiple parameters at the same time for a certain nursing need, they can select these multiple parameters in the parameter list, and then create a target parameter group, and these multiple parameters can be organized as one. When making a selection later, you only need to select the target parameter group to select multiple corresponding parameters at the same time.

提供目标参数组的自适应创建,可以依据医护人员的需求进行生理参数的组合,便于后续参数的选择。It provides self-adaptive creation of target parameter groups, and can combine physiological parameters according to the needs of medical staff, which facilitates the selection of subsequent parameters.

例如,当医护人员选择参数选择标签时,中央站显示参数选择界面401。在参数选择界面401中,402为参数列表,医护人员可以根据临床实际需要选择待查看的生理参数。当医护人员选定需要查看的目标生理参数并关闭401参数选择界面后,在药物统计分析界面的生理参数显示区304显示医护人员所选择的目标生理参数的波形。在参数选择界面401中,403为参数组列表,医护人员可以点击创建参数组按钮,将当前勾选的生理参数作为参数组建立,并在403参数组列表中对创建的参数组进行编辑和删除操作。若医护人员选择勾选参数组列表中的某一参数组并关闭401参数选择界面后,生理参数显示区304为医护人员选择的参数组下对应目标生理参数的波形。这里的显示仅仅是一个例子,并不限于这些参数和药物。For example, when the medical staff selects the parameter selection tab, the central station displays theparameter selection interface 401 . In theparameter selection interface 401, 402 is a parameter list, and the medical staff can select the physiological parameters to be checked according to actual clinical needs. After the medical staff selects the target physiological parameter to be viewed and closes theparameter selection interface 401, the waveform of the target physiological parameter selected by the medical staff is displayed in the physiologicalparameter display area 304 of the drug statistical analysis interface. In theparameter selection interface 401, 403 is a list of parameter groups, and the medical staff can click the Create Parameter Group button to create the currently checked physiological parameters as a parameter group, and edit and delete the created parameter group in the parameter group list at 403 operate. If the medical staff chooses to check a certain parameter group in the parameter group list and closes theparameter selection interface 401, the physiologicalparameter display area 304 is the waveform corresponding to the target physiological parameter under the parameter group selected by the medical staff. The display here is just an example and is not limited to these parameters and drugs.

S343,基于生理参数数据以及目标生理参数,确定目标生理参数数据。S343. Based on the physiological parameter data and the target physiological parameter, determine the target physiological parameter data.

中央站在确定出目标生理参数之后,从所获取到的生理参数数据中提取出目标生理参数数据。After determining the target physiological parameter, the central station extracts the target physiological parameter data from the acquired physiological parameter data.

提供参数选择标签便于医护人员对于不同的目标对象设置不同的生理参数进行显示,从而可以针对目标对象进行个性化设置。The provision of parameter selection labels is convenient for medical staff to set and display different physiological parameters for different target objects, so that personalized settings can be made for the target objects.

S344,响应于对目标选择区中药物选择标签的选择操作,显示药物选择界面。S344, displaying a drug selection interface in response to the selection operation on the drug selection label in the target selection area.

如上文所述,输注系统所监测的输注药物有很多种,而不同的目标对象可能需要监测的输注药物也不同,医护人员所关心的输注药物不同。因此,中央站提供有药物选择标签,以供医护人员针对不同的监护需求选择相应的药物。As mentioned above, there are many kinds of infusion drugs monitored by the infusion system, and different target objects may need to monitor different infusion drugs, and the infusion drugs that medical staff care about are different. Therefore, the central station provides drug selection labels for medical staff to choose corresponding drugs for different monitoring needs.

在需要对输注药物进行选择时,医护人员选择目标选择区中的药物选择标签,相应地,中央站响应于该选择操作,显示药物选择界面。其中,在药物选择界面中提供有多种药物供医护人员选择。When it is necessary to select a drug for infusion, the medical staff selects the drug selection label in the target selection area, and accordingly, the central station displays a drug selection interface in response to the selection operation. Wherein, a plurality of medicines are provided in the medicine selection interface for the medical personnel to choose.

S345,响应于对药物选择界面中药物的选择操作,确定目标药物。S345. Determine the target drug in response to the selection operation of the drug in the drug selection interface.

例如,图10示出了药物选择界面501的一种可选实施方式,在该药物选择界面501中提供有多种药物,医护人员可以根据需求选择其中的一种或多种。中央站将医护人员选中的药物确定为目标药物,该目标药物是显示在药物统计分析界面的药物显示区。For example, Fig. 10 shows an optional implementation of thedrug selection interface 501, in which a variety of drugs are provided, and medical personnel can select one or more of them according to requirements. The central station determines the drug selected by the medical staff as the target drug, and the target drug is displayed in the drug display area of the drug statistical analysis interface.

S346,基于输液数据以及目标药物,确定目标药物的输液数据。S346. Based on the infusion data and the target drug, determine the infusion data of the target drug.

中央站在确定出目标药物之后,在输液数据中进行匹配,确定出该目标药物的输液数据。After the central station determines the target drug, it matches the infusion data to determine the infusion data of the target drug.

通过针对目标对象进行目标药物的个性化选择,对于不同的目标对象配置不同的目标药物,便于医护人员进行监护。Through the personalized selection of target drugs for target objects, different target drugs are configured for different target objects, which is convenient for medical staff to monitor.

在本实施例的一些可选实施方式中,上述S346可以包括:In some optional implementation manners of this embodiment, the above S346 may include:

(1)响应于对目标选择区中药物曲线标签的选择操作,显示药物曲线选择界面。(1) In response to the selection operation of the drug curve label in the target selection area, a drug curve selection interface is displayed.

(2)响应于对药物曲线选择界面中药物属性的选择操作,确定目标药物的药物属性,所述药物属性包括输注速度以及输注累积量。(2) In response to the selection operation of the drug attribute in the drug curve selection interface, determine the drug attribute of the target drug, where the drug attribute includes the infusion rate and the cumulative infusion amount.

(3)基于输液数据、目标药物以及目标药物的药物属性,确定目标药物的输液数据。(3) Determine the infusion data of the target drug based on the infusion data, the target drug, and the drug properties of the target drug.

如图11所示,当医护人员需要对药物的统计信息进行选择时,选择药物曲线标签,相应地,中央站显示药物曲线选择界面601,医护人员在该药物虚线选择界面中进行选择,例如,选中输注速度。相应地,在药物统计分析界面的药物显示区就相应显示目标药物的输注速度随时间变化的曲线。As shown in Figure 11, when the medical personnel need to select the statistical information of the drug, they select the drug curve label, and accordingly, the central station displays the drugcurve selection interface 601, and the medical personnel make a selection in the drug dotted line selection interface, for example, Check the infusion rate. Correspondingly, the curve of the infusion rate of the target drug over time is correspondingly displayed in the drug display area of the drug statistical analysis interface.

或者,也可以同时选中输液速度以及输注累积量。相应地,在药物统计分析界面的药物显示区就同时显示目标药物的输注速度以及输注累积量随时间的变化。Alternatively, the infusion rate and cumulative infusion volume can also be selected at the same time. Correspondingly, the drug display area of the drug statistical analysis interface simultaneously displays the infusion rate of the target drug and the change of the cumulative infusion amount over time.

S35,将目标药物的输液数据显示在药物显示区,并将目标生理参数数据显示在生理参数显示区。S35. Display the infusion data of the target drug in the drug display area, and display the target physiological parameter data in the physiological parameter display area.

具体地,药物选择标签可以方便医护人员设置所需查看的输注药物类型,如图10所示。501是药物选择界面,医护人员可以在该药物选择界面下选择需要进行查看的药物类型,502是药物类型列表,支持医护人员滑动查看,医护人员应该可以进行多选、单选和全选,被选中的药物会用选中符号标识(例如“√”符号),使用不同的背景色标识医护人员操作的状态。若医护人员选择勾选药物类型并关闭501药物选择界面后,药物显示区303为医护人员选择的药物对应的曲线波形。Specifically, the drug selection label can facilitate medical staff to set the type of infusion drug to be viewed, as shown in FIG. 10 . 501 is a drug selection interface, on which the medical staff can select the type of drug to be viewed. 502 is a list of drug types, which supports medical staff to swipe to view. The selected medicine will be marked with a selected symbol (such as "√" symbol), and different background colors will be used to indicate the operating status of the medical staff. If the medical staff chooses to check the type of medicine and closes the 501 medicine selection interface, themedicine display area 303 is the curve waveform corresponding to the medicine selected by the medical staff.

药物曲线标签可以方便医护人员设置所需查看的药物曲线类型,主要包括输注速度曲线和输注累积量,如图11所示。601是药物曲线界面,医护人员可以在该界面下设置查看药物的曲线类型,602是曲线类型列表,医护人员可以进行单选和全选,被选中的曲线会用选中符号标识(例如“√”符号),使用不同的背景色标识医护人员操作的状态。若医护人员选择选择同时显示输注速度曲线和输注累积量曲线并关闭601药物曲线界面后,药物显示区303为某一药物的两种曲线呈现形式,如图11所示效果。The drug curve label is convenient for medical staff to set the type of drug curve to be viewed, mainly including the infusion speed curve and the cumulative infusion volume, as shown in Figure 11. 601 is the drug curve interface, and the medical staff can set the curve type to view the medicine under this interface. 602 is the curve type list, and the medical staff can select single or all, and the selected curve will be marked with a selected symbol (such as "√" symbol), using different background colors to identify the status of medical staff operations. If the medical personnel choose to display the infusion speed curve and the infusion cumulative volume curve at the same time and close the 601 drug curve interface, thedrug display area 303 will display two types of curves for a certain drug, as shown in FIG. 11 .

S36,接收操作对象进行联合分析后,对输液数据的调整设置,并在参数显示区显示调整设置后的输液数据。S36. After receiving the operation object for joint analysis, adjust and set the infusion data, and display the adjusted and set infusion data in the parameter display area.

详细请参见图3所示实施例的S13,在此不再赘述。For details, refer to S13 in the embodiment shown in FIG. 3 , and details are not repeated here.

本实施例提供的监护方法,在药物统计分析界面对药物的输液数据以及目标生理参数数据进行统计分析,便于医护人员了解输注药物对目标对象生命体征的影响,后续可以通过输注药物变化引起的生命体征变化去调整设置药物的剂量、速度,用于辅助临床进行精准护理,操作简单且信呈现的息量大。The monitoring method provided in this embodiment performs statistical analysis on the drug infusion data and target physiological parameter data on the drug statistical analysis interface, which is convenient for medical staff to understand the impact of infused drugs on the vital signs of the target object. Adjust the dosage and speed of the drug according to the changes of vital signs, and use it to assist the clinic in precise nursing. The operation is simple and the information presented is large.

虽然结合附图描述了本发明的实施例,但是本领域技术人员可以在不脱离本发明的精神和范围的情况下做出各种修改和变型,这样的修改和变型均落入由所附权利要求所限定的范围之内。Although the embodiments of the present invention have been described in conjunction with the accompanying drawings, those skilled in the art can make various modifications and variations without departing from the spirit and scope of the present invention. within the bounds of the requirements.

Claims (11)

1. A method of monitoring, comprising:
acquiring physiological parameter data and infusion data of at least one target object at the same time;
displaying the physiological parameter data and the transfusion data in corresponding parameter display areas in a monitoring main interface so as to perform joint analysis on vital sign changes of the target objects, wherein the monitoring main interface comprises a plurality of parameter display areas, and each parameter display area corresponds to each target object;
And after receiving the operation object for joint analysis, adjusting and setting the infusion data, and displaying the adjusted and set infusion data in the parameter display area.
2. The method of claim 1, wherein the monitoring main interface further comprises waveform display areas, each of the waveform display areas corresponding to each of the parameter display areas, the method further comprising:
and displaying the waveform of the physiological parameter data in the waveform display area.
3. The method according to claim 1 or 2, wherein the infusion data includes an infusion remaining time and an infusion alarm identifier, the parameter display area includes a remaining time display area and an alarm display area, and the displaying the physiological parameter data and the infusion data in the corresponding parameter display areas in the monitoring main interface includes:
and displaying the transfusion residual time in the residual time display area of the corresponding parameter display area, and displaying the transfusion alarm mark in the alarm display area of the corresponding parameter display area, wherein the transfusion alarm mark corresponds to the transfusion residual time.
4. The method of claim 1, wherein the parameter display area comprises an infusion display area, the method further comprising:
In response to a selection operation of the infusion display area, displaying a drug statistics analysis interface, wherein the drug statistics analysis interface comprises a drug display area and a physiological parameter display area;
determining infusion data of a target medication and target physiological parameter data in response to a selection operation of the physiological parameter data and the infusion data;
and displaying the infusion data of the target medicine in the medicine display area, and displaying the target physiological parameter data in the physiological parameter display area.
5. The method of claim 4, wherein the medication statistics analysis interface further comprises a target selection area, the determining infusion data for a target medication and target physiological parameter data in response to a selection operation of the physiological parameter data and the infusion data comprising:
responding to the selection operation of the parameter selection label in the target selection area, and displaying a parameter selection interface;
determining the target physiological parameter in response to a selection operation of the physiological parameter in the parameter selection interface;
the target physiological parameter data is determined based on the physiological parameter data and the target physiological parameter.
6. The method of claim 5, wherein the parameter selection interface includes a list of parameters and a list of parameter groups, each entry in the list of parameter groups including at least two physiological parameters, the determining the target physiological parameter in response to a selection operation of a physiological parameter in the parameter selection interface comprising:
the target physiological parameter is determined in response to a selection operation of the parameter list or the parameter set list.
7. The method of claim 5, wherein the determining the target physiological parameter in response to a selection operation of a physiological parameter in the parameter selection interface further comprises:
a set of target parameters is created in response to an operation on the set of target physiological parameters.
8. The method of claim 5, wherein determining infusion data for a target medication and target physiological parameter data in response to a selection operation of the physiological parameter data and the infusion data comprises:
displaying a drug selection interface in response to a selection operation of a drug selection tab in the target selection area;
determining the target drug in response to a selection operation of a drug in the drug selection interface;
And determining infusion data of the target drug based on the infusion data and the target drug.
9. The method of claim 8, wherein the determining infusion data for the target medication based on the infusion data and the target medication comprises:
responding to the selection operation of the drug curve label in the target selection area, and displaying a drug curve selection interface;
determining a drug property of the target drug in response to a selection operation of the drug property in the drug profile selection interface, the drug property comprising an infusion rate and an infusion accumulation;
determining infusion data for the target medication based on the infusion data, the target medication, and a medication attribute of the target medication.
10. A central station, comprising:
the monitoring system comprises a display interface, a memory and a processor, wherein the display interface, the memory and the processor are in communication connection, the memory stores computer instructions, and the processor executes the computer instructions so as to execute the monitoring method of any one of claims 1-9.
11. A central monitoring system, comprising:
The infusion system is used for acquiring infusion data of a target object;
the physiological parameter monitoring device is used for acquiring physiological parameter data of the target object;
the central station of claim 10, communicatively coupled to the infusion system and the physiological parameter monitoring device.
CN202111328097.5A2021-11-102021-11-10Monitoring method, central station and central monitoring systemPendingCN116099080A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202111328097.5ACN116099080A (en)2021-11-102021-11-10Monitoring method, central station and central monitoring system

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202111328097.5ACN116099080A (en)2021-11-102021-11-10Monitoring method, central station and central monitoring system

Publications (1)

Publication NumberPublication Date
CN116099080Atrue CN116099080A (en)2023-05-12

Family

ID=86262553

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202111328097.5APendingCN116099080A (en)2021-11-102021-11-10Monitoring method, central station and central monitoring system

Country Status (1)

CountryLink
CN (1)CN116099080A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101496923A (en)*2009-03-102009-08-05中山大学Critical illness monitoring, infusion controlling, diagnosis and treatment integrated system and control method thereof
CN202395815U (en)*2011-11-162012-08-22乌维磊Wireless WiFi (Wireless Fidelity) medical monitoring management system
US20170043089A1 (en)*2015-08-142017-02-16Baxter International Inc.Medical device data integration apparatus and methods
CN109621086A (en)*2019-01-112019-04-16防灾科技学院 A convenient patient intelligent monitoring system in medical places

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101496923A (en)*2009-03-102009-08-05中山大学Critical illness monitoring, infusion controlling, diagnosis and treatment integrated system and control method thereof
CN202395815U (en)*2011-11-162012-08-22乌维磊Wireless WiFi (Wireless Fidelity) medical monitoring management system
US20170043089A1 (en)*2015-08-142017-02-16Baxter International Inc.Medical device data integration apparatus and methods
CN109621086A (en)*2019-01-112019-04-16防灾科技学院 A convenient patient intelligent monitoring system in medical places

Similar Documents

PublicationPublication DateTitle
CA3030643C (en)User interface for configurably displaying real-time data for multiple patients
US12046364B2 (en)System and method for a patient dashboard
US20200357493A1 (en)Monitoring, capturing, measuring and annotating physiological waveform data
US10460408B2 (en)Presentation of critical patient data
CN102905616B (en)Multi-Display Bedside Monitoring System
JP7123608B2 (en) Medical data presentation device and medical data presentation program
US10303850B2 (en)Medical assistance device, operation method and program for medical assistance device, and medical assistance system for temporary medical information display with pointer-over operation
KR20160147753A (en)Medical services tracking system and method
JP2017508532A (en) Patient monitoring and treatment intervention / event timeline
US11587653B2 (en)Graphical user interface for tracking and displaying patient information over the course of care
US20220157423A1 (en)Intraoperative clinical decision support system
JP6097949B2 (en) Graph display device, method of operating graph display device, and graph display program
EP2422695A2 (en)Monitoring patients receiving care
US20170230632A1 (en)Time series data display control device, method for operating the same, program, and system
US20200227162A1 (en)Hospital information system and image data generation method
WO2020199119A1 (en)Monitor, and method for combined display of physiological sign parameters and medication information for same
US20170024516A1 (en)Information analysis assistance device, operation method and operation program thereof, and information analysis assistance system
US20170228900A1 (en)Time series data display control device, method for operating the same, program, and system
US20070094227A1 (en)System and method for clinical decision support
US20200279651A1 (en)Medical examination support apparatus, and operation method and operation program thereof
US20220246300A1 (en)Diagnosis assistance apparatus and diagnosis assistance system
US9978165B2 (en)Dynamic presentation of waveform tracings in a central monitor perspective
WO2020124313A1 (en)Patient state monitoring method, medical monitoring device, and computer readable storage medium
CN116099080A (en)Monitoring method, central station and central monitoring system
US20170046020A1 (en)Medical assistance device, operation method and operation program thereof, and medical assistance system

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination

[8]ページ先頭

©2009-2025 Movatter.jp